The EU Cleared the $25 Billion Axalta Deal With a European Refinish Carve-Out: PPG and Sherwin-Williams Get a Smaller Rival, Not a Bigger One

The Commission approved the merger of Axalta and AkzoNobel on November 6, 2026 with one condition attached: AkzoNobel must divest its European vehicle refinish coatings business, and the transaction cannot close until the Commission approves the purchaser. The divestment strips out the only segment where the two companies genuinely overlapped, and the Commission found no other problematic market in the EEA, the United Kingdom or Switzerland.

Vehicle refinish behaves like a consumer brand sold through an installer network. A body shop buys one basecoat and clearcoat system, mixes the colour in one mixer, trains its staff on it, and repaints the same vehicle for years. That stickiness is why the Commission's interest landed on refinish, and why it chose to remove a business rather than accept behavioural promises from the parties.

Conditional clearance removes a regulatory risk, not an operating one. Axalta went into the announcement with third-quarter sales up 1.8% and operating income down 20% year over year, and it cut full-year guidance three weeks before the clearance landed.

The exchange ratio settles the economics before any synergy does. Axalta shareholders receive 0.6539 AkzoNobel shares per Axalta share and end up with 45% of a group whose own guidance is roughly €25 billion of enterprise value on about €3.3 billion of adjusted EBITDA including synergies — close to 7.6 times.

Read the scorecard as a transfer of quality, not of scale. Axalta contributes the lowest gross margin in the US peer set at 32.6% and hands shareholders 45% of a group whose guided economics sit below the multiple they traded at, while PPG and Sherwin-Williams keep both their franchises and their multiples. The carve-outs also shrink the group's revenue before the savings arrive, with roughly $500 million of annual sales leaving and a €2.5 billion dividend still to be paid at close.

Procurement is one of the four named sources of the €600 million, and the suppliers on the other side of that ledger are in the weakest financial shape in years. Chemours lifted Titanium Technologies segment sales 11% to $680 million in the third quarter of 2026 on 10% price increases, with segment adjusted EBITDA tripling to $85 million from $25 million — a price cycle turning, not a supplier with room to concede.

Put the two halves together and the procurement target is being negotiated in a market turning against the buyer: pigment prices are rising, supplier margins are recovering from a floor, and the European network the plan wants to consolidate is the one the Commission wants sold. The synergy that carries the valuation is the one part of the deal the remedy directly interferes with

Over the next two quarters the only new information that matters for Axalta is the purchaser's identity and the price attached to the carve-out. The Commission has cleared the transaction, so what is left is procedural: a purchaser it will not accept, a US review still open after the February 20, 2026 second request, and a divestment that takes longer to sell than the parties assume.

Over one to three years the question is whether a group that has just sold two businesses can still deliver €600 million of savings while titanium dioxide prices keep climbing. Three numbers decide it: who owns the divested European franchise, the net leverage the group carries into the first full year, and whether Axalta's Performance Coatings line recovers once the European refinish volume drag works through.

Conditional clearance does not make this a scale story. It makes it a story about where the scale was allowed to go, and about who ends up holding the profitable piece of a business that just got smaller on paper. For coatings investors the trade is simpler than the headlines: a capped rival in refinish, a buyer with pricing power over pigment, and a target that has to re-rate its own multiple to justify swapping it. The remedy protects the incumbent moats more than it protects the acquirer's